Silver Book Fact

Treating cancer patients with oral medicine versus intravenous chemotherapy results in a 2/3 reduction in hospital time and a greater than 50% reduction in costly medication side effects.

Twelves C. Oral Chemotherapy Saves Resources and Time. Reuters Medical News. 12-Jun-2001

Reference

Title
Oral Chemotherapy Saves Resources and Time
Publication
Reuters Medical News
Publication Date
12-Jun-2001
Authors
Twelves C

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Since 1980, 83 percent of gains in life expectancy for cancer patients have been attributable to new treatments.  
  • According to the Pharmaceutical Research and Manufacturers of America, a cancer medicine in the pipeline would inhibit production of a protein that may interfere with the effectiveness of chemotherapy.  
  • In the U.S., new cancer drugs have increased life expectancy at birth by 10.7%.  
  • Treating cancer patients with oral medicine versus intravenous chemotherapy results in a 2/3 reduction in hospital time and a greater than 50% reduction in costly medication side effects.  
  • The overall five-year survival rate for men with prostate cancer is 99 percent—up from 43 percent in 1975.